Tuesday, September 01, 2020 9:51:44 AM
I swear my heart skipped a beat when I read it.
It scares me just a little bit to ponder what this could mean. Coverage by Medicaid and Medicare? One of the requirements is for the device to be covered by commercial insurers. How does one go about this? I will presume Dr. Staelin has contacts in the FDA and the insurance industry. The most recent letter to shareholders, including, and especially, not having a safe harbor statement, was a 'thing of beauty'. I am desperately hoping that BIEL, via Dr. Staelin, is working on this. Should we become a MCIT-covered device, how far would that go to make us, our technology, the Actipatch, Standard of Care?
https://www.massdevice.com/cms-agrees-to-cove...l-devices/
MCIT-covered devices would also have to fit Medicare statutory definitions of “Reasonable and Necessary” for treating patients. To that end, the proposed rule would refine the definitions of “Reasonable and Necessary.” Among the requirements, devices would need to be considered:
• Safe and effective. ===>> good to go; head to toe
• Not experimental or investigational. ===>> FDA cleared for full body
• Appropriate for Medicare patients, including the duration and
frequency that is considered appropriate and whether it is
covered by commercial insurers.
later, WBeacham
To find out who your rulers are, simply find out who you can not criticize in public
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM